| Period Ending | 02-Feb-2013 | 27-Oct-2012 | 30-Jul-2012 | 28-Apr-2012 |
|---|
|
Total Revenue
|
9,350,000
|
6,075,000
|
6,118,000
|
6,143,000
| | Cost of Revenue | 5,554,000 | 3,672,000 | 3,555,000 | 3,757,000 | | |
Gross Profit
|
3,796,000
|
2,403,000
|
2,563,000
|
2,386,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 2,400,000 | 2,078,000 | 2,009,000 | 1,995,000 |
|
Non Recurring | 5,000 |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
1,391,000
|
325,000
|
554,000
|
391,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (136,000) | 1,000 |
-
| 1,000 |
|
Earnings Before Interest And Taxes | 1,255,000 | 326,000 | 554,000 | 392,000 |
|
Interest Expense | 103,000 | 104,000 | 105,000 | 113,000 |
|
Income Before Tax | 1,152,000 | 222,000 | 449,000 | 279,000 |
|
Income Tax Expense | 422,000 | 77,000 | 170,000 | 98,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 593,000 | 145,000 | 279,000 | 181,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
730,000
|
145,000
|
279,000
|
181,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
730,000
|
145,000
|
279,000
|
181,000
|
|
0.17(0.34%) 1:13AM - Nasdaq Real Time Price